Background: Laboratory diagnosis of SARS-CoV-2 infection (the cause of COVID-19) uses
PCR to detect viral RNA (vRNA) in respiratory samples. SARS-CoV-2 RNA has also been …

Background The progression and geographical distribution of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection in the United Kingdom (UK) and elsewhere is …

Hepatitis B virus (HBV) is a unique, tiny, partially double-stranded, reverse-transcribing DNA
virus with proteins encoded by multiple overlapping reading frames. The substitution rate is …

Background The Global Hepatitis Health Sector Strategy is aiming for “elimination of viral
hepatitis as a public health threat” by 2030 [1], while enhanced elimination efforts for hepatitis …

The COVID-19 pandemic caused by the SARS-CoV-2 virus has resulted in a myriad of
interventions with the urgent aim of reducing the public health impact of this virus. However, a …

Prior studies have demonstrated that immunologic dysfunction underpins severe illness in
COVID-19 patients, but have lacked an in-depth analysis of the immunologic drivers of death …

Advancing interventions to tackle the huge global burden of hepatitis B virus (HBV) infection
depends on improved insights into virus epidemiology, transmission, within-host diversity, …

Background Measuring the incidence of HIV and hepatitis C virus (HCV) infection among
people who inject drugs (PWID) is key to track progress towards elimination. We aimed to …

Background: Stigma, poverty, and lack of knowledge present barriers to the diagnosis and
treatment of chronic infection, especially in resource-limited settings. Chronic Hepatitis B virus …

Hepatocellular carcinoma (HCC) is one of the leading contributors to cancer mortality
worldwide and is a leading cause of death in individuals with chronic hepatitis B virus (HBV) …